Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2021

Open Access 01-12-2021 | Arthritis | Research article

Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis

Authors: Alison Hammond, Yeliz Prior, Sarah Cotterill, Chris Sutton, Elizabeth Camacho, Calvin Heal, Jo Adams, Yvonne Hough, Terence W. O’Neill, Jill Firth

Published in: BMC Musculoskeletal Disorders | Issue 1/2021

Login to get access

Abstract

Background

Arthritis (or compression) gloves are widely prescribed to people with rheumatoid arthritis and other forms of hand arthritis. They are prescribed for daytime wear to reduce hand pain and improve hand function, and/or night-time wear to reduce pain, improve sleep and reduce morning stiffness. However, evidence for their effectiveness is limited. The aims of this study were to investigate the clinical and cost effectiveness of arthritis gloves compared to placebo gloves on hand pain, stiffness and function in people with rheumatoid arthritis and persistent hand pain.

Methods

A parallel randomised controlled trial, in adults (≥ 18 years) with rheumatoid or undifferentiated inflammatory arthritis at 16 National Health Service sites in the UK. Patients with persistent hand pain affecting function and/or sleep were eligible. Randomisation (1:1) was stratified by recent change (or not) in medication, using permuted blocks of random sizes. Three-quarter-finger length arthritis gloves (Isotoner®: applying 23-32 mmHg pressure) (intervention) were compared to loose-fitting placebo gloves (Jobskin® classic: providing no/minimal pressure) (control). Both gloves (considered to have similar thermal qualities) were provided by occupational therapists. Patients and outcome assessors were blinded; clinicians were not. The primary outcome was dominant hand pain on activity (0–10) at 12 weeks, analysed using linear regression and intention to treat principles.

Results

Two hundred six participants were randomly assigned (103 per arm) and 163 (84 intervention: 79 control) completed 12-week follow-up. Hand pain improved by 1.0 (intervention) and 1.2 (control), an adjusted mean difference of 0.10 (95% CI: − 0.47 to 0.67; p = 0.72). Adverse events were reported by 51% of intervention and 36% of control group participants; with 6 and 7% respectively, discontinuing glove wear. Provision of arthritis gloves cost £129, with no additional benefit.

Conclusion

The trial provides evidence of no clinically important effect of arthritis gloves on any of the trial outcomes (hand pain, function and stiffness) and arthritis gloves are not cost-effective. The clinical and cost-effectiveness results support ceasing provision of arthritis gloves in routine clinical practice. Funding: National Institute for Health Research.

Trial registration

ISRCTN, ISRCTN25892131; Registered 05/09/2016: retrospectively registered.
Appendix
Available only for authorised users
Literature
2.
go back to reference Seto Y, Inoue E, Shikara K, Hoshi D, Sugimoto N, Sato E, et al. Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study. Med Rheumatol. 2013;23:1179–85.CrossRef Seto Y, Inoue E, Shikara K, Hoshi D, Sugimoto N, Sato E, et al. Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study. Med Rheumatol. 2013;23:1179–85.CrossRef
3.
go back to reference Horsten NCA, Ursum J, Roorda LD, van Schaardenburg D, Dekker J, Hoeksma AF. Prevalence of hand symptoms, impairments and activity limitations in rheumatoid arthritis in relation to disease duration. J Rehabil Med. 2010;42:916–21.PubMedCrossRef Horsten NCA, Ursum J, Roorda LD, van Schaardenburg D, Dekker J, Hoeksma AF. Prevalence of hand symptoms, impairments and activity limitations in rheumatoid arthritis in relation to disease duration. J Rehabil Med. 2010;42:916–21.PubMedCrossRef
4.
go back to reference Prior Y, Hammond A. The survey of rheumatology occupational therapy glove practice and provision in the UK. Rheumatology. 2015;54:i101. Prior Y, Hammond A. The survey of rheumatology occupational therapy glove practice and provision in the UK. Rheumatology. 2015;54:i101.
5.
go back to reference Hammond A, Jones V, Prior Y. The effects of compression gloves on hand symptoms and hand function in rheumatoid arthritis and hand osteoarthritis: a systematic review. Clin Rehabil. 2016;30(3):213–24.PubMedCrossRef Hammond A, Jones V, Prior Y. The effects of compression gloves on hand symptoms and hand function in rheumatoid arthritis and hand osteoarthritis: a systematic review. Clin Rehabil. 2016;30(3):213–24.PubMedCrossRef
6.
go back to reference Oosterveld FJG, Rasker JJ. The effect of pressure gradient and thermolactyl control gloves in arthritis patients with swollen hands. Br J Rheumatol. 1990;29:197–200.PubMedCrossRef Oosterveld FJG, Rasker JJ. The effect of pressure gradient and thermolactyl control gloves in arthritis patients with swollen hands. Br J Rheumatol. 1990;29:197–200.PubMedCrossRef
7.
go back to reference McKnight PT, Kwoh CK. Randomised controlled trial of pressure gloves in rheumatoid arthritis. Arthritis Care Res. 1999;5:223–7.CrossRef McKnight PT, Kwoh CK. Randomised controlled trial of pressure gloves in rheumatoid arthritis. Arthritis Care Res. 1999;5:223–7.CrossRef
10.
go back to reference Research Nester. Therapy Gloves Market Segmentation by Size (Small, Medium, Large); By Product Type (Compression gloves, thermal gloves and splint gloves); By Design (Open Finger Gloves, Full Finger Gloves and Wrist Wraps); By Material Type (Cotton and Synthetic Fibre); By End User (Physiotherapy Centres; Home Care and Others); − Global Demand Analysis and Opportunity Outlook 2020–2027. Available from: https://www.researchnester.com/reports/therapy-gloves-market/1882. Cited 2020 May 23. Research Nester. Therapy Gloves Market Segmentation by Size (Small, Medium, Large); By Product Type (Compression gloves, thermal gloves and splint gloves); By Design (Open Finger Gloves, Full Finger Gloves and Wrist Wraps); By Material Type (Cotton and Synthetic Fibre); By End User (Physiotherapy Centres; Home Care and Others); − Global Demand Analysis and Opportunity Outlook 2020–2027. Available from: https://​www.​researchnester.​com/​reports/​therapy-gloves-market/​1882. Cited 2020 May 23.
11.
go back to reference Culic DD, Battaglia MC, Wichman C, Schmid FR. Efficacy of compression gloves in rheumatoid arthritis. Am J Phys Med. 1979;58:278–84.PubMed Culic DD, Battaglia MC, Wichman C, Schmid FR. Efficacy of compression gloves in rheumatoid arthritis. Am J Phys Med. 1979;58:278–84.PubMed
12.
go back to reference Swezey RL, Spiegel TM, Cretin S, Clements P. Arthritic hand response to pressure gradient gloves. Arch Phys Med Rehabil. 1979;60:375–7.PubMed Swezey RL, Spiegel TM, Cretin S, Clements P. Arthritic hand response to pressure gradient gloves. Arch Phys Med Rehabil. 1979;60:375–7.PubMed
13.
go back to reference Dixon A, St J, Harrison RA, Pocock P. Trial of Isotoner gloves for morning stiffness and pain in rheumatoid arthritis. Br J Clin Pract. 1986;40:271–2.PubMed Dixon A, St J, Harrison RA, Pocock P. Trial of Isotoner gloves for morning stiffness and pain in rheumatoid arthritis. Br J Clin Pract. 1986;40:271–2.PubMed
15.
go back to reference Prior Y, Sutton C, Cotterill S, Adams J, Camacho E, Arafin N, et al. The effects of arthritis gloves on people with rheumatoid arthritis: or inflammatory arthritis with hand pain: a study protocol for a multicentre randomised controlled trial (the A-GLOVES trial). BMC Musculoskeletal Dis. 2017;18:224.CrossRef Prior Y, Sutton C, Cotterill S, Adams J, Camacho E, Arafin N, et al. The effects of arthritis gloves on people with rheumatoid arthritis: or inflammatory arthritis with hand pain: a study protocol for a multicentre randomised controlled trial (the A-GLOVES trial). BMC Musculoskeletal Dis. 2017;18:224.CrossRef
16.
go back to reference Kiltz U, von Zabern U, Baraliakos X, Heldman F, Mintrop B, Sarholz M, et al. Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis – the TryCort study. Arth Res Ther. 2017;19:273.CrossRef Kiltz U, von Zabern U, Baraliakos X, Heldman F, Mintrop B, Sarholz M, et al. Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis – the TryCort study. Arth Res Ther. 2017;19:273.CrossRef
19.
go back to reference Heine PJ, Williams MA, Williamson E, Bridle C, Adams J, O’Brien A, et al. Development and delivery of an exercise intervention for rheumatoid arthritis: strengthening and stretching for rheumatoid arthritis of the hand (SARAH) trial. Physiotherapy. 2012;98:121–30.PubMedCrossRef Heine PJ, Williams MA, Williamson E, Bridle C, Adams J, O’Brien A, et al. Development and delivery of an exercise intervention for rheumatoid arthritis: strengthening and stretching for rheumatoid arthritis of the hand (SARAH) trial. Physiotherapy. 2012;98:121–30.PubMedCrossRef
21.
go back to reference Jones LE, White P, Donovan-Hall M, Hislop K, Boucas SB, Adams J. The thoughts and feelings held by clinicians about the delivery of a placebo thumb splint in an osteoarthritis rehabilitation trial. Hand Therapy. 2013;18:77–83.CrossRef Jones LE, White P, Donovan-Hall M, Hislop K, Boucas SB, Adams J. The thoughts and feelings held by clinicians about the delivery of a placebo thumb splint in an osteoarthritis rehabilitation trial. Hand Therapy. 2013;18:77–83.CrossRef
23.
go back to reference Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain. Arthritis Care Res. 2011;63(Suppl 11):S240–52.CrossRef Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain. Arthritis Care Res. 2011;63(Suppl 11):S240–52.CrossRef
24.
go back to reference Wolfe F, Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rheumatol. 2007;34:1674–8.PubMed Wolfe F, Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rheumatol. 2007;34:1674–8.PubMed
25.
go back to reference Strand V, Boers M, Idzerda L, Kirwan JR, Kvien TR, Tugwell PS, et al. It's good to feel better but It's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10. J Rheumatol. 2011;38:1720–7.PubMedCrossRef Strand V, Boers M, Idzerda L, Kirwan JR, Kvien TR, Tugwell PS, et al. It's good to feel better but It's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10. J Rheumatol. 2011;38:1720–7.PubMedCrossRef
26.
go back to reference Strand V, Schiff M, Tundia M, Friedman A, Meerwein S, Pangan A, et al. Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs. Arthritis Res Ther. 2019;21:263.PubMedPubMedCentralCrossRef Strand V, Schiff M, Tundia M, Friedman A, Meerwein S, Pangan A, et al. Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs. Arthritis Res Ther. 2019;21:263.PubMedPubMedCentralCrossRef
27.
go back to reference Prior Y, Tennant A, Tyson S, Kjeken I, Hammond A. Measure of activity performance of the hand (MAP-hand) questionnaire: linguistic validation, cultural adaptation and psychometric testing in people with rheumatoid arthritis in the UK. BMC Musculoskelet Disord. 2018;19:275.PubMedPubMedCentralCrossRef Prior Y, Tennant A, Tyson S, Kjeken I, Hammond A. Measure of activity performance of the hand (MAP-hand) questionnaire: linguistic validation, cultural adaptation and psychometric testing in people with rheumatoid arthritis in the UK. BMC Musculoskelet Disord. 2018;19:275.PubMedPubMedCentralCrossRef
28.
go back to reference Chung KC, Pillsbury MS, Walters MR, Hayward RA. Reliability and validity testing of the Michigan hand outcomes questionnaire. J Hand Surg [Am]. 1998;23:575–87.CrossRef Chung KC, Pillsbury MS, Walters MR, Hayward RA. Reliability and validity testing of the Michigan hand outcomes questionnaire. J Hand Surg [Am]. 1998;23:575–87.CrossRef
29.
go back to reference London D, Stepan JG, Calfee RP. Determining the Michigan hand outcomes questionnaire minimal clinically important difference by means of three methods. Plast Reconstr Surg. 2014;133(3):616–25.PubMedCrossRef London D, Stepan JG, Calfee RP. Determining the Michigan hand outcomes questionnaire minimal clinically important difference by means of three methods. Plast Reconstr Surg. 2014;133(3):616–25.PubMedCrossRef
30.
go back to reference Kirwan JR, Reeback JS. Stanford health assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol. 1986;25:206–9. Kirwan JR, Reeback JS. Stanford health assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol. 1986;25:206–9.
31.
go back to reference EuroQol group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef EuroQol group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef
32.
go back to reference StataCorp. Stata Statistical Software: Release 14. College Station: StataCorp LP; 2015. StataCorp. Stata Statistical Software: Release 14. College Station: StataCorp LP; 2015.
35.
go back to reference Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ. 1996;5(2):141–54.PubMedCrossRef Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ. 1996;5(2):141–54.PubMedCrossRef
40.
go back to reference Lamb SE, Williamson EM, Heine PJ, Adams J, Dosanjh S, Dritsaki M, et al. Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial. Lancet. 2015;385(9966):421–9.PubMedCrossRef Lamb SE, Williamson EM, Heine PJ, Adams J, Dosanjh S, Dritsaki M, et al. Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial. Lancet. 2015;385(9966):421–9.PubMedCrossRef
41.
go back to reference Hammond A, Freeman K. The long-term outcomes from a randomised controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis. Clin Rehabil. 2004;18:520–8.PubMedCrossRef Hammond A, Freeman K. The long-term outcomes from a randomised controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis. Clin Rehabil. 2004;18:520–8.PubMedCrossRef
Metadata
Title
Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis
Authors
Alison Hammond
Yeliz Prior
Sarah Cotterill
Chris Sutton
Elizabeth Camacho
Calvin Heal
Jo Adams
Yvonne Hough
Terence W. O’Neill
Jill Firth
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2021
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-020-03917-8

Other articles of this Issue 1/2021

BMC Musculoskeletal Disorders 1/2021 Go to the issue